Protocol for a prospective, randomized, controlled trial of Mental Contrasting with Implementation Intentions (MCII) to enhance the effectiveness of VA’s MOVE! weight management program: WOOP (Wish, Outcome, Obstacle, Plan) VA

By sjmartinez • April 14, 2024

Vandyousefi S, Oettingen G, Wittleder S, Moin T, Sweat V, Aguilar AD, Ruan A, Angelotti G, Wong L, Orstad SL, Illengberger N, Nicholson A, Lim S, Cansler R, Portelli D, Sherman S, Jay MR. Protocol for a prospective, randomized, controlled trial of Mental Contrasting with Implementation Intentions (MCII) to enhance the effectiveness of VA's MOVE! weight management program: WOOP (Wish, Outcome, Obstacle, Plan) VA. Contemp Clin Trials. 2024 Apr 10:107523. doi: 10.1016/j.cct.2024.107523. Epub ahead of print. PMID: 38608752.

Tags: Behavior change, Endocrinology, Mental contrasting, MOVE!, Obesity, Publications, Veterans, weight loss, WOOP

Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program

Wang N, DiCorpo DA, Zhang Y, Kleinbrink E, Arnett DK, Barnard J, Blangero J, Bowden DW, Carson AP, Chen YI, Chung MK, Curran JE, Darbar[...]

Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1

Lim A, Peluso EM, Downs IA, Horwich BH, Velez-Velez MA, Lechner MG. Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome[...]

Updates in Cystic Fibrosis Related Diabetes (CFRD)

Zelada H, Kaput KL, Runchey S, Le TN. Updates in Cystic Fibrosis Related Diabetes (CFRD). Endocr Pract. 2026 Jun 9:S1530-891X(26)01031-1. doi: 10.1016/j.eprac.2026.05.038. Epub ahead of[...]